Levalbuterol hydrochloride

DA Handley, J Morley, L Vaickus - Expert opinion on …, 1998 - Taylor & Francis
Racemic salbutamol (racemic albuterol) ameliorates symptoms of asthma by activating b-
adrenoceptors on nerve, smooth muscle and inflammatory cells within the airways. Racemic …

Long‐acting inhaled β2‐agonists in the management of asthma: recent advances and current recommendations

AE Redington, PJ Rees - International journal of clinical …, 1998 - Wiley Online Library
Salmeterol and formoterol belong to a new class of inhaled β2‐agonists with a prolonged
duration of action. At the time these agents were introduced, there was uncertainty regarding …

Chronic treatment in vivo with β‐adrenoceptor agonists induces dysfunction of airway β2‐adrenoceptors and exacerbates lung inflammation in mice

R Lin, S Degan, BS Theriot, BM Fischer… - British journal of …, 2012 - Wiley Online Library
BACKGROUND AND PURPOSE Inhalation of a β‐adrenoceptor agonist (β‐agonist) is first‐
line asthma therapy, used for both prophylaxis against, and acute relief of …

Long-and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi

M Molimard, E Naline, Y Zhang… - European …, 1998 - Eur Respiratory Soc
The aim of this study was to systematically compare the interaction of the long-acting beta2-
adrenoceptor agonists formoterol and salmeterol with short-acting beta2-adrenoceptor …

Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled β2-adrenoceptor agonists

EM Rosethorne, RJ Turner, RA Fairhurst… - Naunyn-Schmiedeberg's …, 2010 - Springer
Inhaled β 2 adrenoceptor (β 2 AR) agonists are widely used as bronchodilator therapies for
asthma and COPD. Different agonists have varying rates of onset of action, eg indacaterol …

Inhaled β2-agonists in asthma management: an evolving story

D Silva, T Jacinto - Breathe, 2016 - Eur Respiratory Soc
Inhaled β2-agonists in asthma management: an evolving story | European Respiratory
Society Skip to main content Main menu Home Current issue Past issues Authors/reviewers …

Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism

NA Hanania, BF Dickey, RA Bond - Current opinion in pulmonary …, 2010 - journals.lww.com
Rational choice among β 2-AR agonists in acute and chronic asthma should be influenced
by differences in intrinsic efficacy among these agents. In acute severe asthma, a full agonist …

What is New with the β2-Agonists: Issues in the Management of Asthma

HW Kelly - Annals of Pharmacotherapy, 2005 - journals.sagepub.com
OBJECTIVE: To review the more recent literature addressing the issue of whether β2-
agonists can worsen asthma and/or increase the risk of severe exacerbations and death …

(R)-salbutamol in the treatment of asthma and chronic obstructive airways disease

M Patel, NC Thomson - Expert opinion on pharmacotherapy, 2011 - Taylor & Francis
Introduction: Asthma and chronic obstructive pulmonary disease (COPD) are inflammatory
disorders that have an increasing prevalence and associated morbidity and mortality. β2 …

Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma

S Durham - European Respiratory Journal, 1999 - Eur Respiratory Soc
The introduction of long-acting inhaled sympathomimetic b2-receptor agonists represents an
important advance in asthma therapy. Treatment with salmeterol and formoterol provides …